mdl 72527 and Anterior Optic Neuritis

mdl 72527 has been researched along with Anterior Optic Neuritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alfarhan, M; Baker, L; Henry-Ojo, HO; Liao, Y; Liu, F; Narayanan, SP; Shenoy, N; Somanath, PR	1

Other Studies

1 other study(ies) available for mdl 72527 and Anterior Optic Neuritis

Article	Year
Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis. Cells, 2022, 12-16, Volume: 11, Issue:24 Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Inflammation; Mice; Models, Theoretical; Multiple Sclerosis; Optic Nerve; Optic Neuritis; Retinal Ganglion Cells; Visual Acuity	2022

Article

Year

Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis.

Cells, 2022, 12-16, Volume: 11, Issue:24

Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Inflammation; Mice; Models, Theoretical; Multiple Sclerosis; Optic Nerve; Optic Neuritis; Retinal Ganglion Cells; Visual Acuity

2022